Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/47410
Title: | International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2013-2018, Adult and Pediatric Units, Device-associated Module | Authors: | Daniel Rosenthal, Victor Duszynska, Wieslawa Ider, Bat-Erdene Gurskis, Vaidotas Al-Ruzzieh, Majeda A. Myatra, Sheila Nainan Gupta, Debkishore Belkebir, Souad Upadhyay, Namita Zand, Farid Todi, Subhash Kumar Kharbanda, Mohit Nair, Pravin K. Mishra, Sanghamitra Chaparro, Gustavo Mehta, Yatin Zala, Dolatsinh Janc, Jaroslaw Aguirre-Avalos, Guadalupe Aguilar-De-Moros, Daisy Estela Hernandez-Chena, Blanca Gün, Emrah Öztoprak Çuvalcı, Nefise Yıldızdaş, Dinçer Abdelhalim, Mona Moheyeldin Özturk Deniz, Suna Seçil Gan, Chin Seng Nguyen Viet Hung Joudi, Hala Omar, Abeer Aly Gikas, Achilleas El-Kholy, Amani Ali Barkat, Amina Koirala, Anjeela Cerero-Gudino, Antonio Bouziri, Asma Gomez-Nieto, Katherine Fisher, Dale Medeiros, Eduardo A. Salgado-Yepez, Estuardo Horhat, Florin Agha, Hala Mounir Moustafa Cesar Vimercati, Julio Villanueva, Victoria Jayatilleke, Kushlani Le Thi Thu Nguyet Raka, Lul Guadalupe Miranda-Novales, Maria Petrov, Michael Mihailov Apisarnthanarak, Anucha Tayyab, Nadia Elahi, Naheed Mejia, Nepomuceno Morfin-Otero, Rayo Al-Khawaja, Safa Anguseva, Tanja Gupta, Umesh Belskii, Vladislav A. Mat, Wan Rahiza Wan Giovanny Chapeta-Parada, Edwin Guanche-Garcell, Humberto Pattnaik, Saroj Kumar Pandya, Nirav Poojary, Aruna Ananda Chawla, Rajesh Mahfouz, Tahsine Kanj, Souha S. Mioljevic, Vesna Hlinkova, Sona Mrazova, Mariana Al-Abdely, Hail M. Güçlü, Ertuğrul Özgültekin, Asu Baytaş, Volkan Tekin, Recep Yalçın, Ata Nevzat Erben, Nurettin |
Keywords: | Bacterial resistance Device-associated infection Health care-associated infection Hospital infection Limited resources countries Nosocomial infection amikacin ceftazidime ciprofloxacin colistin imipenem oxacillin vancomycin adult antibiotic resistance Article catheter infection child cohort analysis device infection disease surveillance Enterococcus healthcare associated infection hospital infection human infection control intensive care unit Klebsiella length of stay major clinical study medical device complication nonhuman pediatric intensive care unit prospective study Pseudomonas aeruginosa Staphylococcus Staphylococcus aureus treatment duration urinary tract infection ventilator associated event bacterial infection catheter infection cross infection intensive care unit urinary tract infection ventilator associated pneumonia Adult Bacterial Infections Catheter-Related Infections Child Cross Infection Humans Infection Control Intensive Care Units Pneumonia, Ventilator-Associated Prospective Studies Urinary Tract Infections |
Publisher: | Mosby Inc. | Abstract: | Background: We report the results of INICC surveillance study from 2013 to 2018, in 664 intensive care units (ICUs) in 133 cities, of 45 countries, from Latin-America, Europe, Africa, Eastern-Mediterranean, Southeast-Asia, and Western-Pacific. Methods: Prospective data from patients hospitalized in ICUs were collected through INICC Surveillance Online System. CDC-NHSN definitions for device-associated healthcare-associated infection (DA-HAI) were applied. Results: We collected data from 428,847 patients, for an aggregate of 2,815,402 bed-days, 1,468,216 central line (CL)-days, 1,053,330 mechanical ventilator (MV)-days, 1,740,776 urinary catheter (UC)-days. We found 7,785 CL-associated bloodstream infections (CLAB), 12,085 ventilator-associated events (VAE), and 5,509 UC-associated urinary tract infections (CAUTI). Pooled DA-HAI rates were 5.91% and 9.01 DA-HAIs/1,000 bed-days. Pooled CLAB rate was 5.30/1,000 CL-days; VAE rate was 11.47/1,000 MV-days, and CAUTI rate was 3.16/1,000 UC-days. P aeruginosa was non-susceptible (NS) to imipenem in 52.72% of cases; to colistin in 10.38%; to ceftazidime in 50%; to ciprofloxacin in 40.28%; and to amikacin in 34.05%. Klebsiella spp was NS to imipenem in 49.16%; to ceftazidime in 78.01%; to ciprofloxacin in 66.26%; and to amikacin in 42.45%. coagulase-negative Staphylococci and S aureus were NS to oxacillin in 91.44% and 56.03%, respectively. Enterococcus spp was NS to vancomycin in 42.31% of the cases. Conclusions: DA-HAI rates and bacterial resistance are high and continuous efforts are needed to reduce them. © 2021 | URI: | https://doi.org/10.1016/j.ajic.2021.04.077 https://hdl.handle.net/11499/47410 |
ISSN: | 0196-6553 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu |
Show full item record
CORE Recommender
SCOPUSTM
Citations
62
checked on Oct 13, 2024
Page view(s)
58
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.